F8 and autoimmune hemolytic anemia: Administration of desmopressin, which stimulates the release of FVIII and VWF from endothelial cells and can provide a transient rise in FVIII:C levels to therapeutic levels [68], may also be effective in AHA patients with low titers of inhibitors or an FVIII:C level >5% [64].